Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$534M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$391M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$375M |
| 4 |
AABA
Altaba Inc. Common Stock
AABA
|
+$353M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$318M |
Top Sells
| 1 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$506M |
| 2 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$345M |
| 3 |
Lowe's Companies
LOW
|
+$234M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$215M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$164M |
Sector Composition
| 1 | Technology | 11.79% |
| 2 | Financials | 10.8% |
| 3 | Consumer Discretionary | 6.75% |
| 4 | Healthcare | 6.63% |
| 5 | Industrials | 5.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Topgolf Callaway Brands
MODG
$1.78B
| $1.95M | ﹤0.01% |
118,961
+37,140
| +45% | +$608K |
|
1427
Novavax
NVAX
$1.34B
| $1.95M | ﹤0.01% |
46,300
+17,558
| +61% | +$738K |
|
1428
Vanguard Mid-Cap Growth ETF
VOT
$17.9B
| $1.94M | ﹤0.01% |
14,982
+1,162
| +8% | +$151K |
|
1429
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$868M
| $1.93M | ﹤0.01% |
158,299
+4,552
| +3% | +$55.4K |
|
1430
Invesco
IVZ
$10.1B
| $1.92M | ﹤0.01% |
60,032
-198,909
| -77% | -$6.37M |
|
1431
Portland General Electric
POR
$4.65B
| $1.92M | ﹤0.01% |
47,431
+14,932
| +46% | +$605K |
|
1432
Madrigal Pharmaceuticals
MDGL
$9.79B
| $1.92M | ﹤0.01% |
16,438
+14,802
| +905% | +$1.73M |
|
1433
FibroGen
FGEN
$50.3M
| $1.92M | ﹤0.01% |
1,661
-2,277
| -58% | -$2.63M |
|
1434
Bio-Rad Laboratories Class A
BIO
$7.74B
| $1.92M | ﹤0.01% |
7,662
-35,423
| -82% | -$8.85M |
|
|
BRS
1435
DELISTED
Bristow Group, Inc.
BRS
| $1.91M | ﹤0.01% |
146,766
+146,354
| +35,523% | +$1.9M |
|
1436
iShares MSCI Peru and Global Exposure ETF
EPU
$178M
| $1.91M | ﹤0.01% |
44,740
-5,770
| -11% | -$246K |
|
|
NATI
1437
DELISTED
National Instruments Corp
NATI
| $1.89M | ﹤0.01% |
37,379
+26,922
| +257% | +$1.36M |
|
1438
Fidelity International Value Factor ETF
FIVA
$266M
| $1.89M | ﹤0.01% |
+80,000
| New | +$1.89M |
|
1439
WisdomTree
WT
$2.08B
| $1.89M | ﹤0.01% |
205,732
+57,488
| +39% | +$527K |
|
1440
XPO
XPO
$15.8B
| $1.87M | ﹤0.01% |
53,141
+29,648
| +126% | +$1.04M |
|
|
CIM
1441
Chimera Investment
CIM
$1.17B
| $1.87M | ﹤0.01% |
35,778
-22,106
| -38% | -$1.15M |
|
1442
Boot Barn
BOOT
$5.76B
| $1.86M | ﹤0.01% |
104,949
+24,986
| +31% | +$443K |
|
1443
Henry Schein
HSIC
$8.43B
| $1.85M | ﹤0.01% |
35,121
-23,210
| -40% | -$1.22M |
|
1444
Air Lease Corp
AL
$7.1B
| $1.85M | ﹤0.01% |
43,378
-27,540
| -39% | -$1.17M |
|
1445
Schwab International Equity ETF
SCHF
$51.5B
| $1.85M | ﹤0.01% |
110,686
-406
| -0.4% | -$6.78K |
|
|
SPPI
1446
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.85M | ﹤0.01% |
114,875
-51,217
| -31% | -$824K |
|
1447
Selective Insurance
SIGI
$4.85B
| $1.85M | ﹤0.01% |
30,446
-2,335
| -7% | -$142K |
|
1448
Atkore
ATKR
$2.09B
| $1.84M | ﹤0.01% |
92,918
-28,775
| -24% | -$571K |
|
1449
Cathay General Bancorp
CATY
$3.4B
| $1.83M | ﹤0.01% |
45,856
+35,257
| +333% | +$1.41M |
|
1450
Ultragenyx Pharmaceutical
RARE
$3.01B
| $1.83M | ﹤0.01% |
35,879
-5,240
| -13% | -$267K |
|